Saturday, 14 November 2026European Markets

WDP And MONTEA Have A High Dividend Yield And Return On Equity In The REIT - Industrial Industry.

Automated market report from our archive (2020–2024), published before source-traceability. How we work

Loading stream...

(VIANEWS) - WDP (WDP.BR) is among this list of stock assets with the highest dividend rate and return on equity on the REIT - Industrial industry.

Financial Asset Price Forward Dividend Yield Return on Equity
WDP (WDP.BR) €25.20 4.46% 0.58%
MONTEA (MONT.BR) €77.30 4.38% 8.42%

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. WDP (WDP.BR)

4.46% Forward Dividend Yield and 0.58% Return On Equity

WDP develops and invests in logistics property (warehouses and offices). WDP has over 7 million m² of properties in its portfolio. This international portfolio of semi-industrial and logistics buildings is spread over about 300 sites at prime logistics hubs for storage and distribution in Belgium, France, the Netherlands, Luxembourg, Germany and Romania.

Earnings Per Share

As for profitability, WDP has a trailing twelve months EPS of €-1.06.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 0.58%.

Volatility

WDP's last week, last month's, and last quarter's current intraday variation average was a positive 0.79%, a negative 0.12%, and a positive 0.93%.

WDP's highest amplitude of average volatility was 0.91% (last week), 0.77% (last month), and 0.93% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth grew by 14%, now sitting on 400.42M for the twelve trailing months.

Yearly Top and Bottom Value

WDP's stock is valued at €25.20 at 11:40 EST, way under its 52-week high of €28.94 and way above its 52-week low of €22.16.

Sales Growth

WDP's sales growth for the current quarter is 18.1%.

More news about WDP.

2. MONTEA (MONT.BR)

4.38% Forward Dividend Yield and 8.42% Return On Equity

Montea NV is a public regulated real estate company under Belgian law (GVV/SIR) that specializes in logistics real estate in Belgium, the Netherlands, France, and Germany. The company is a benchmark player in this market. Montea literally offers its customers the space to grow through versatile and innovative property solutions. In this way, Montea creates value for its shareholders. As of 31/12/2023 the property portfolio represented a total surface of 1,959,242 m², spread across 95 locations. Montea NV has been listed on Euronext Brussels (MONT) and Euronext Paris (MONTP) since the end of 2006.

Earnings Per Share

As for profitability, MONTEA has a trailing twelve months EPS of €6.46.

PE Ratio

MONTEA has a trailing twelve months price to earnings ratio of 11.97. Meaning, the purchaser of the share is investing €11.97 for every euro of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.42%.

Yearly Top and Bottom Value

MONTEA's stock is valued at €77.30 at 11:40 EST, way under its 52-week high of €88.20 and way higher than its 52-week low of €61.90.

More news about MONTEA.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com